Published in Braz J Med Biol Res on January 10, 2014
Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management. Breast Cancer Res (2015) 1.12
miR-193b Modulates Resistance to Doxorubicin in Human Breast Cancer Cells by Downregulating MCL-1. Biomed Res Int (2015) 0.83
Exploring circulating micro-RNA in the neoadjuvant treatment of breast cancer. Int J Cancer (2016) 0.80
Differential microRNA expression is associated with androgen receptor expression in breast cancer. Mol Med Rep (2016) 0.75
Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer. Cell Death Dis (2017) 0.75
Effect of SMYD3 on the microRNA expression profile of MCF-7 breast cancer cells. Oncol Lett (2017) 0.75
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet (2008) 32.08
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res (2005) 29.17
MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther (2008) 3.06
Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol Cancer Ther (2008) 2.85
Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer. Nat Med (2010) 2.62
Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem Pharmacol (2008) 2.56
EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. Nat Med (2011) 2.46
Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases. Breast Cancer Res Treat (2003) 2.14
Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells. J Biol Chem (2003) 1.95
FoxM1 dances with mitosis. Nat Cell Biol (2005) 1.85
Polo-like kinase 1 (Plk1) inhibits p53 function by physical interaction and phosphorylation. J Biol Chem (2004) 1.80
Retracted miR-221 promotes tumorigenesis in human triple negative breast cancer cells. PLoS One (2013) 1.77
14-3-3 proteins as potential oncogenes. Semin Cancer Biol (2006) 1.72
Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer. Mol Cancer Ther (2006) 1.64
MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11. Nat Commun (2013) 1.43
Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK. Cancer Biol Ther (2007) 1.38
MiR-26a inhibits proliferation and migration of breast cancer through repression of MCL-1. PLoS One (2013) 1.25
MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer. Breast Cancer Res Treat (2010) 1.23
Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer. Cell Cycle (2013) 1.23
miR-30 family members negatively regulate osteoblast differentiation. J Biol Chem (2012) 1.22
Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance. Int J Cancer (2004) 1.16
Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone. Breast Cancer Res (2010) 1.14
Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1. Oncol Rep (2013) 1.07
MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion. Breast Cancer Res Treat (2012) 1.07
Silencing of 14-3-3ζ over-expression in hepatocellular carcinoma inhibits tumor growth and enhances chemosensitivity to cis-diammined dichloridoplatium. Cancer Lett (2011) 1.05
Interactions of c-Raf-1 with phosphatidylserine and 14-3-3. Oncogene (1999) 1.01
miR-421 and miR-30c inhibit SERPINE 1 gene expression in human endothelial cells. PLoS One (2012) 0.97
Micro-RNA30c negatively regulates REDD1 expression in human hematopoietic and osteoblast cells after gamma-irradiation. PLoS One (2012) 0.95
Multiple tumor-associated microRNAs modulate the survival and longevity of dendritic cells by targeting YWHAZ and Bcl2 signaling pathways. J Immunol (2013) 0.93
Tumor stem cell niches: a new functional framework for the action of anticancer drugs. Recent Pat Anticancer Drug Discov (2006) 0.86
MicroRNA-regulated protein-protein interaction networks and their functions in breast cancer. Int J Mol Sci (2013) 0.85
Polymorphism in pre-miR-30c contributes to gastric cancer risk in a Chinese population. Med Oncol (2011) 0.83
Activation of the p38 and JNK/SAPK mitogen-activated protein kinase pathways during apoptosis is mediated by a novel retinoid. Exp Cell Res (1999) 0.83
Sulfuretin-induced miR-30C selectively downregulates cyclin D1 and D2 and triggers cell death in human cancer cell lines. Biochem Biophys Res Commun (2013) 0.80
[Single nucleotide polymorphism in flanking region of miR-30c influences the maturing process of miR-30c in lung carcinoma]. Zhonghua Zhong Liu Za Zhi (2012) 0.76